Recruiting

The Effect of Mindfulness-Based Breathing Exercises on Symptom Control

ClinicalTrials.gov IDNCT07474337

PhaseNA

Enrollment72

SponsorFirat University

Age18 Years

SexFEMALE

I'm interested View official listing

Conditions studied

Breast Cancer

About this study

This randomized controlled experimental study aims to evaluate the effect of mindfulness-based breathing exercises on symptom management and salivary cortisol levels in breast cancer patients receiving chemotherapy. The study population will consist of breast cancer patients undergoing chemotherapy treatment in the Oncology Department of Fırat University Hospital. A total of 72 patients who meet the inclusion criteria and volunteer to participate will be included in the study, with 36 patients in the experimental group and 36 in the control group. Data will be collected using the Personal Information Form and the Edmonton Symptom Assessment Scale. The findings of this study are expected to provide evidence regarding the effectiveness of mindfulness-based breathing exercises in improving symptom management and reducing stress levels in breast cancer patients receiving chemotherapy.

Interventions

Behavioral: Mindfulness-Based Breathing Exercise — Mindfulness-based breathing exercises focusing attention on breathing to promote awareness and support symptom management in breast cancer patients receiving chemotherapy.

Primary outcomes

Symptom Severity (Baseline and after the intervention period (e.g., 8 weeks))

Eligibility information

Inclusion Criteria: * Being over 18 years of age * Knowing their diagnosis * Receiving chemotherapy for the first time due to a breast cancer diagnosis * Having breast cancer stages I, II, or III (stage 4 patients were not included in the study as metastatic spread would increase symptoms and make communication with the patient difficult), * Not receiving treatment for another cancer, * Not having a physical disability that would prevent telephone interviews (hearing, speech), * Not having any psychiatric disorder that would impair comprehension and understanding, * Patients who have verbally and in writing consented to participate in the study will be included in the research. Exclusion Criteria: * Patients with communication problems • Patients with psychiatric problems

Study locations

Gül DURAL, Elâzığ, Turkey (Türkiye)

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.